BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 17227625)

  • 41. [Absorption of triterpenoid compounds from Indian bread (Poria cocos) across human intestinal epithelial (Caco-2) cells in vitro].
    Zheng Y; Yang XW
    Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(13):1596-601. PubMed ID: 18837324
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Baicalein, an alpha-glucosidase inhibitor from Scutellaria baicalensis.
    Nishioka T; Kawabata J; Aoyama Y
    J Nat Prod; 1998 Nov; 61(11):1413-5. PubMed ID: 9834167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Transport of genistein-7-glucoside by human intestinal CACO-2 cells: potential role for MRP2.
    Walle UK; French KL; Walgren RA; Walle T
    Res Commun Mol Pathol Pharmacol; 1999 Jan; 103(1):45-56. PubMed ID: 10440570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prediction of intestinal absorption and metabolism of pharmacologically active flavones and flavanones.
    Serra H; Mendes T; Bronze MR; Simplício AL
    Bioorg Med Chem; 2008 Apr; 16(7):4009-18. PubMed ID: 18249545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolism of flavonoids via enteric recycling: role of intestinal disposition.
    Chen J; Lin H; Hu M
    J Pharmacol Exp Ther; 2003 Mar; 304(3):1228-35. PubMed ID: 12604700
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Studies on metabolites of baicalin in human urine].
    Che QM; Huang XL; Li YM; Kun Z; Teruaki A; Masao H
    Zhongguo Zhong Yao Za Zhi; 2001 Nov; 26(11):768-9. PubMed ID: 12776350
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A combined cell based approach to identify P-glycoprotein substrates and inhibitors in a single assay.
    Balimane PV; Chong S
    Int J Pharm; 2005 Sep; 301(1-2):80-8. PubMed ID: 16023314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transport of the flavonoid chrysin and its conjugated metabolites by the human intestinal cell line Caco-2.
    Walle UK; Galijatovic A; Walle T
    Biochem Pharmacol; 1999 Aug; 58(3):431-8. PubMed ID: 10424761
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic study of baicalein after oral administration in monkeys.
    Tian S; He G; Song J; Wang S; Xin W; Zhang D; Du G
    Fitoterapia; 2012 Apr; 83(3):532-40. PubMed ID: 22245084
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetic interactions among major bioactive components in Radix Scutellariae via metabolic competition.
    Li CR; Zhang L; Wo SK; Zhou LM; Lin G; Zuo Z
    Biopharm Drug Dispos; 2012 Dec; 33(9):487-500. PubMed ID: 22933367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin.
    Shieh DE; Liu LT; Lin CC
    Anticancer Res; 2000; 20(5A):2861-5. PubMed ID: 11062694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The absorption characterization effects and mechanism of Radix Angelicae dahuricae extracts on baicalin in Radix Scutellariae using in vivo and in vitro absorption models.
    Liang XL; Liao ZG; Zhu JY; Zhao GW; Yang M; Yin RL; Cao YC; Zhang J; Zhao LJ
    J Ethnopharmacol; 2012 Jan; 139(1):52-7. PubMed ID: 22023882
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Baicalin, a prodrug able to reach the CNS, is a prolyl oligopeptidase inhibitor.
    Tarragó T; Kichik N; Claasen B; Prades R; Teixidó M; Giralt E
    Bioorg Med Chem; 2008 Aug; 16(15):7516-24. PubMed ID: 18650094
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of targeting property for Kuikang colon targeted pellets].
    Zhang YJ; Li JY; Xu LY
    Zhongguo Zhong Yao Za Zhi; 2008 Jul; 33(13):1556-7, 1604. PubMed ID: 18837313
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Kinetic difference of baicalin in rat blood and cerebral nuclei after intravenous administration of Scutellariae Radix extract.
    Zhang L; Xing D; Wang W; Wang R; Du L
    J Ethnopharmacol; 2006 Jan; 103(1):120-5. PubMed ID: 16159703
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatic contribution to a marked increase in the plasma concentration of baicalin after oral administration of its aglycone, baicalein, in multidrug resistance-associated protein 2-deficient rat.
    Akao T; Sato K; Hanada M
    Biol Pharm Bull; 2009 Dec; 32(12):2079-82. PubMed ID: 19952434
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
    Yu L; Zeng S
    J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Urinary pharmacokinetics of baicalein, wogonin and their glycosides after oral administration of Scutellariae Radix in humans.
    Lai MY; Hsiu SL; Chen CC; Hou YC; Chao PD
    Biol Pharm Bull; 2003 Jan; 26(1):79-83. PubMed ID: 12520178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. An Agent-Based Approach to Dynamically Represent the Pharmacokinetic Properties of Baicalein.
    Zhu X; Deng J; Zuo Z; Lam TN
    AAPS J; 2016 Nov; 18(6):1475-1488. PubMed ID: 27480317
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Disposition of flavonoids via enteric recycling: enzyme-transporter coupling affects metabolism of biochanin A and formononetin and excretion of their phase II conjugates.
    Jia X; Chen J; Lin H; Hu M
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1103-13. PubMed ID: 15128864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.